{
    "organizations": [],
    "uuid": "6a752009a19a56368fbe2267ef78e7b245c0b570",
    "author": "Charley Grant",
    "url": "https://www.wsj.com/articles/investors-brace-yourselves-for-more-drug-price-drama-1526463001",
    "ord_in_thread": 0,
    "title": "Investors, Brace Yourselves for More Drug-Price Drama",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "The next leg of the Trump administrationâ€™s plan to lower the cost of drug prices could get ugly for investors.\nAs soon as Thursday the Food and Drug Administration plans to publish a database of complaint letters from generic drug companies to the agency alleging anticompetitive activities from branded pharmaceutical companies. It is likely that some complaints will pertain to high-price blockbuster drugs that investors watch most closely.\n... To Read the Full Story Subscribe Sign In",
    "published": "2018-05-16T13:30:00.000+03:00",
    "crawled": "2018-05-16T17:29:06.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "next",
        "leg",
        "trump",
        "administration",
        "plan",
        "lower",
        "cost",
        "drug",
        "price",
        "could",
        "get",
        "ugly",
        "investor",
        "soon",
        "thursday",
        "food",
        "drug",
        "administration",
        "plan",
        "publish",
        "database",
        "complaint",
        "letter",
        "generic",
        "drug",
        "company",
        "agency",
        "alleging",
        "anticompetitive",
        "activity",
        "branded",
        "pharmaceutical",
        "company",
        "likely",
        "complaint",
        "pertain",
        "blockbuster",
        "drug",
        "investor",
        "watch",
        "closely",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}